ECDC is monitoring reports from three countries (France, the United Kingdom and the United States) of cases of invasive meningococcal disease (IMD) associated with travel to the Kingdom of Saudi Arabia (KSA).
Between 15 March and 6 July 2021, 348 confirmed S. Braenderup sequence type 22 (ST22) cases were reported in 12 European Union/European Economic Area (EU/EEA) countries and the United Kingdom (UK).
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
Between May 2018 and December 2020, 193 human cases of Salmonella Enteritidis sequence type (ST)11 were reported in Denmark (2), Finland (4), France (33), Germany (6), Ireland (12), the Netherlands (3), Poland (5), Sweden (6), and the United Kingdom (UK) (122). One in five cases was hospitalised. One death was reported. Fifty percent of the cases were children ≤ 18 years. The most recent case was reported by the UK in December 2020.
Since the latest ECDC-EFSA rapid outbreak assessment published on 12 December 2017, 15 EU/EEA countries (Belgium, Czech Republic, Denmark, France, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Slovenia, Sweden and United Kingdom) have reported 336 confirmed, 94 probable and 3 new historical-confirmed cases associated with this ongoing multi-country outbreak of Salmonella Enteritidis in the EU/EEA.
A multi-country outbreak of Salmonella enterica subspecies enterica serovar Agona (S. Agona) is under investigation in the European Union (EU), with cases retrospectively identified back to 2014.
This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Agona associated with consumption of potentially contaminated infant formula from France.
Since the previous ECDC epidemiological update was published on 30 June 2017, seven EU/EEA countries (Belgium, France, Luxembourg, the Netherlands, Norway, Sweden and the United Kingdom) have reported 96 confirmed and 34 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis with MLVA profiles 2-9-7-3-2 or 2-9-6-3-2 ongoing in the EU/EEA.
Since the ECDC and EFSA joint rapid outbreak assessment was published on 7 March 2017, six EU Member States (Belgium, France, Italy, Norway, Sweden and the United Kingdom) have reported 50 confirmed and 12 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis phage type 8 infections (MLVA profiles 2-9-7-3-2 and 2-9-6-3-2) ongoing in the EU/EEA. In addition, twelve probable cases have been reclassified as confirmed.
An outbreak of S. Enteritidis phage type 8 is ongoing in the EU/EEA. Isolates are part of two distinct but related genetic clusters. ECDC and EFSA are liaising with relevant authorities to facilitate the coordination of investigation response measures.